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IntroductIon
one  of  the  features  of  asthma  is  persistent  pul‑
monary  inflammation  with  increased  numbers  of 
activated  t‑lymphocytes,  eosinophils  and  macro‑
phages/monocytes, and resident tissue cells. these 
cells play a role in establishment and maintenance 
of the chronic inflammatory process by releasing a 
wide repertoire of cytokines, chemokines, and other 
proinflammatory  mediators.  there  is  increasing 
evidence that reactive oxygen and nitrogen species 
are also important mediators of the inflammatory 
process, providing a cellular mechanism that links 
oxidative stress and chronic inflammation. oxidants 
are a well‑characterized source of cellular injury at 
multiple  levels,  and  they  are  believed  to  produce 
many of the features typical of asthma (caramori 
and Papi, 2004). on the other hand, as intracellu‑
lar molecular messengers, they regulate specific and 
redox‑dependent  signaling  pathways  modulating 
the expression of a variety of genes, among which 
are  the  genes  coding  for  cytokines  (Morel  and 
Barouki, 1999).
Binding of a ligand to the glucocorticoid recep‑
tor  (Gr)  is  an  important  step  in  regulation  and 
modulation  of  glucocorticoid  signal  transduction. 
upon interaction with a steroid, the Gr becomes 
activated to a form that can interact with specific 
regulatory  dnA  elements  in  the  promoter  region 
of  glucocorticoid‑sensitive  genes,  thereby  modify‑
ing their transcription. Alternatively, the activated 
receptor can exert its transactivation or transrepres‑
sion  activity  by  interacting  with  other  regulatory 
proteins,  thus  mediating  most  of  the  anti‑inflam‑
matory  and  immunosuppressive  actions  of  gluco‑
corticoid hormones. Extensive studies have shown 
that the Gr is subject to redox modulation in vitro 
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(Silva and cidlowski, 1989; Meshinchi et 
al., 1990), as well as in vivo (Makino et al., 1996; 
Galigniana  et  al.,  1999).  By  virtue  of  being  a 
redox‑sensitive  transcription  factor,  the  Gr  is  a 
potential target through which reactive species can 
modulate  the  expression  of  glucocorticoid‑depen‑
dant  genes  especially  in  asthma,  where  reactive 
oxygen  species  are  important  factors  of  the  dis‑
ease pathogenesis (caramori and Papi, 2004). 
Additionally, oxidative stress and proinflammatory 
mediators can enhance the inflammatory response 
and modulate corticosteroid function by repression 
of HdAc2 activity (Ito et al., 2004). Attenuation of 
this activity was found to be associated with nitra‑
tion of the enzyme’s tyrosine residues, which can be 
provoked by H2o2 or peroxynitrite.
In this study, we performed initial experiments 
to  test  a  hypothesis  that  the  pathogenesis  and/or 
maintenance  of  the  chronic  disease  in  asthmatic 
patients can be attributed to defects in Gr function 
possibly resulting from the action of oxidants. to 
that end, we conducted a series of ex vivo treatments 
of peripheral lymphocytes with oxidizing agents and 
compared resulting Gr functional alterations with 
the  alterations  previously  registered  in  asthmatic 
patients with mild and moderate asthma (Perišić 
et al., 2008). 
MAtErIAlS And MEtHodS
Blood sampling and cell isolation
Blood  samples  were  obtained  from  healthy  adult 
volunteers  by  venipuncture.  Blood  was  collected 
in  heparinized  tubes  (25  u/ml),  and  peripheral 
blood  mononuclear  cells  (PBMcs)  were  isolated 
within one hour from blood drawing. to isolate the 
cells,  blood  was  diluted  with  an  equal  volume  of 
phosphate‑buffered saline (PBS) (0.14 mmol/l nacl, 
2.7 mmol/l  kcl,  1.5 mmol/l  kH2Po4,  6.5 mmol/l 
na2HPo4; pH 7.2) and subjected to density gradient 
centrifugation  over  Ficoll‑Paque  Plus  (Amersham 
Biosciences) at 380 x g for 30 min at 23ºc. the cells 
were thoroughly washed with PBS and resuspended 
in rPMI‑1640 medium (Gibco/Invitrogen) supple‑
mented  with  2 mM  glutamine,  25  mM  HEPES, 
and 10% heat‑inactivated fetal bovine serum (FBS) 
(Gibco/Invitrogen). cell viability, evaluated by the 
trypan  Blue  dye  exclusion  method,  was  always 
found to be greater than 95%. the PBMcs that were 
not used immediately were rapidly frozen in liquid 
nitrogen.
Hormone binding assay
the cell suspension was adjusted to a final density 
of  5x106  cells/ml.  Aliquots  of  mononuclear  cells, 
containing  1x106  cells  each,  were  incubated  with 
[3H]dexamethasone (Amersham Biosciences, spec. 
act. 34 to 40 ci/mmol) at five or six different concen‑
trations (depending on PBMc yield) ranging from 5 
to 120 nM in triplicate in the absence or presence of 
a 100‑fold molar excess of unlabeled dexamethasone 
(Sigma chemical co., Mo, uSA) to determine total 
and nonspecific binding, respectively. After 2 h of 
incubation in a water bath at 37ºc, all tubes were 
placed on ice and the reaction stopped by adding 1 
ml of ice‑cold PBS. Following three cycles of washing 
at 4ºc with PBS and centrifugation at 1000 x g for 
5 min at 4ºc, the final pellets were resuspended in 
PBS and transferred to 3 ml of a scintillation cocktail 
(Ecoscint H, national diagnostic Inc). radioactivity 
measurements were performed in a rackbeta scin‑
tillation counter (lkB) with approximately 50% effi‑
ciency for tritium. Specific binding was calculated 
by subtracting the nonspecific from total binding at 
each dexamethasone concentration. to assess inter‑
assay  variation,  repeated  measurements  were  per‑
formed on different occasions. For determination of 
the Gr number, an intra‑individual variation of 18% 
was registered, while the coefficient of variation for 
its hormone–binding affinity was found to be 22%, 
these data being in agreement with existing reports 
(Hearing et al., 1999; Hagendorf et al., 2005). 
the number of receptor sites per cell and apparent 
dissociation  constant  (kd)  were  calculated  using 
computer‑assisted nonlinear regression curve fitting 
procedure and assuming competitive binding to one 
class of binding sites.
Treatment of PBMCs with oxidizing agents
Mononuclear cells were isolated and resuspended in 
rPMI‑1640 medium containing 2 mM glutamine, 
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the cells were incubated in the presence of 1 mM 
3‑morpholinosydnonimine  hydrochloride  (SIn‑1, 
Sigma chemical co), 1 mM S‑nitroso‑n‑acetylpen‑
icillamine (SnAP, Sigma chemical co.), or 1 mM 
H2o2 (Sigma chemical co.) for 6 h at 37ºc. the 
first  of  these  agents  (SIn‑1)  releases  superoxide 
anion (o2ˉ) and nitrogen monoxide (no) in equi‑
molar  quantities,  thereby  producing  peroxynitrite 
anion (ono2¯), whereas SnAP is a pure no donor. 
treatment with SIn‑1 was performed according to 
Martin‑romero et al. (2004). Briefly, in order 
to obtain a steady‑state concentration of short‑lived 
ono2¯  during  6  h,  we  applied  sequential  SIn‑1 
pulses  to  simulate  chronic  exposure.  the  initial 
90 mM stock solution of SIn‑1 was freshly prepared 
in  acidic  buffer  (pH 5.0)  and  kept  on  ice  in  the 
dark.
After the treatment, the medium was replaced 
by fresh medium and cell viability was estimated. 
An  aliquot  of  the  mononuclear  cell  suspension 
from each treatment was stored in liquid nitrogen 
for subsequent analysis. the rest was subjected to 
radioligand‑binding  assay  and  analyzed  for  Gr 
binding parameters.
Cellular protein extraction
For protein extraction, cellular pellets (1×106 cells) 
were  resuspended  in  15  μl  of  ice  cold  hypotonic 
lysis  buffer  (50  mmol/l  nacl,  5%  glycerol,  0.5% 
triton X‑100, 2 mmol/l ethylenediaminetetraacetic 
acid,  and  50  mmol/l  tris;  pH  7.5)  supplemented 
with a complete protease inhibitor cocktail (roche 
diagnostics  GmbH).  Following  incubation  on  ice 
for 15 min and two freeze/thaw cycles, the lyzate 
was centrifuged at 13,000 x g for 15 min at 4ºc. the 
supernatants, referred to as whole cell extracts, were 
stored in small portions at ‑75ºc. Protein concentra‑
tion ranged from 3 to 6 μg/μl.
Western blotting
the  proteins  were  reduced  and  denatured  by 
5‑min  treatment  at  95ºc  with  a  buffer  contain‑
ing  62.5 μM  tris  (pH 6.8),  2% SdS,  10%  glycerol, 
5%  β‑mercaptoethanol,  and  0.0075%  bromphenol 
blue. the proteins (70 μg per lane) were resolved 
on 7.5% SdS‑PA gel, together with protein molecu‑ PA gel, together with protein molecu‑
lar  mass  standards  (29‑205 kda,  Sigma chemical Sigma  chemical 
co.). After overnight transfer, PvdF membranes .  After  overnight  transfer,  PvdF  membranes 
(Hybond‑P, Amersham Biosciences) were incubated Amersham Biosciences) were incubated  were incubated 
in a blocking buffer containing 2.5% nonfat dry milk 
in PBS (pH 7.2) for 1.5 h at room temperature. the 
Gr was detected using two different anti‑Gr polyclo‑
nal antibodies: PA1‑511A (1:1000 dilution; Affinity 
Bioreagents, Golden, co) and Gr M‑20 (1:500 dilu‑
tion; Santa cruz Biotechnology, Santa cruz, cA). 
the former antibody, herein designated Ab1, was 
raised against an immunizing peptide correspond‑
ing to amino acid residues 346‑367 of the human 
Gr  (cidlowski  et  al.,  1990).  the  latter  anti‑
body, designated Ab2, was raised against n‑terminal 
amino  acids  of  murine  Gr.  After  three  cycles 
of  washing  with  PBS  containing  0.1%  tween 20, 
the membranes were incubated for 1 h with alka‑
line  phosphatase‑conjugated  secondary  antibody. 
the  immunoreactive  protein  bands  were  visual‑
ized  on  StorM  (Amersham  Pharmacia  Biotech 
uk  limited,  England)  by  an  enhanced  chemif‑
luorescent method (EcF, Amersham Biosciences). Amersham Biosciences). . 
the membranes were reprobed with mouse mono‑
clonal anti‑β‑actin antibody (1:8000 dilution; Sigma  anti‑β‑actin antibody (1:8000 dilution; Sigma 
chemical co.) to verify equal protein load in each 
lane. Since protein nitration was used as a measure 
of ono2¯ formation, monoclonal anti‑nitrotyrosine 
antibody (1:500; upstate Biotechnology Inc., lake 1:500; upstate Biotechnology Inc., lake lake 
Placid,  nY) was also used. For positive control, ) was also used. For positive control,   was  also  used.  For  positive  control, 
BSA  at  10 mg/ml  in  PBS  (pH 7.4)  was  incubated 
with 10 mM SIn‑1 for 2 h at 37ºc. relative inte‑
grated optical density of immunoreactive bands was 
measured using Image Quant software (Amersham 
Biosciences limited, uk) and the results expressed 
in arbitrary units (Au).
Statistical analyses
the relative levels of Gr protein and its functional 
parameters  before  and  after  the  treatments  were 
compared  by  the  nonparametric  kruskal‑Wallis 
test,  followed  by  an  appropriate  post  hoc  test. 
Between‑group differences were analyzed with the 
Mann‑Whitney  u‑test,  or  with  the  t‑test,  where 
appropriate. A two‑tailed p value of less than 0.05 
was considered significant. Statistical comparisons 
were carried out using GraphPad Prism, version 4.0 
(GraphPad Prism Software Inc., San diego, cA).t. PErIšIć Et Al. 534
Fig. 1. Effect of oxidizing agents on GR binding parameters in 
PBMCs of healthy adult donors. (A) Representative saturation 
curves of [3H]dexamethasone binding in untreated and treated 
cells. Cumulative quantitative data on (B) GR binding affinity 
and (C) the number of  hormone-binding sites per cell in un-
treated and in cells treated with 1 mM SIN 1, 1 mM SNAP, or 1 
mM H2O2. The results are expressed as means ± SEM for two 
independent experiments. **: p<0.005 compared to untreated 
control (t test).
rESultS
to examine the effects of several different oxidiz‑
ing  agents  on  Gr  ligand–binding  parameters  in 
PBMcs, a set of experiments was performed using 
freshly isolated PBMcs obtained from the blood of 
healthy adult donors. Pilot experiments were car‑
ried  out  to  determine  optimal  conditions  for  cell 
treatment  that  produced  no  effect  on  viability  of 
the  cells,  as  measured  by  the  trypan  Blue  exclu‑
sion method. cells were treated with 1 mM SIn‑1, 
1  mM  SnAP,  and  1 mM  H2o2 and  subsequently 
assayed for [3H]dexamethasone binding. Figure 1A 
shows  [3H]dexamethasone  binding  curves  before 
and after treatment of PBMcs with oxidizing agents. 
the equilibrium dissociation constant (kd) of the 
hormone‑receptor interaction, calculated from the 
binding curves by computer‑assisted analysis, was 
increased by treatment with SIn‑1 (57.3 ± 5.9 nM; 
p=0.003) and H2o2 (82.3 ± 10.0 nM; p=0.003), but 
remained  unchanged  after  treatment  with  SnAP 
(12.6 ± 1.3 nM)  as  compared  to  kd  in  untreated 
PBMcs (10.3 ± 2.4 nM) (Fig. 1B). on the premise 
that  kd  is  inversely  proportional  to  the  receptor’s 
affinity  for  the  hormone,  the  results  demonstrate 
that    treatment  with  SIn‑1  and  H2o2  led  to  a 
decrease  of  the  receptor’s  ligand‑binding  affinity, 
while SnAP left it unchanged. Furthermore, after 
treatment  with  SIn‑1  the  number  of  dexametha‑
sone‑binding sites per cell was severely decreased 
(606 ± 127; p=0.007) in comparison with untreated 
cells (4125 ± 852). In contrast, treatment with H2o2 
caused an elevation in the number of receptor sites 
in PBMcs (12556 ± 1174; p=0.006), whereas treat‑
ment with SnAP did not affect it (4010 ± 511, n=2) 
(Fig. 1c).
When Western blot analysis of Gr bands was 
done using Ab1 antibody, a specific pattern of the 
Gr bands was obtained both before and after treat‑
ment with oxidants. In untreated cells, in addition 
to a rather weak 94‑kda band, corresponding to the 
full‑length  Gr,  immunospecific  bands  migrating 
at approximately 60, 55, 50, 45, and 29 kda, cor‑
responding to truncated Gr molecules, were also 
detected (Fig. 2A, upper left panel). A similar pattern 
of immunoreactive bands was obtained with PBMcs 
of another blood donor (Fig. 2A, upper right panel). 
treatment with SIn‑1 reduced the intensity of all 
immunoreactive  protein  bands,  especially  those 
with lower molecular masses. the pattern obtained 
after treatment with SnAP resembled that found in 
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other  hand,  H2o2 treatment  yielded  a  prominent 
band migrating at around 60 kda, while reactivity 
of  the  50‑  and  29‑kda  bands  was  comparable  to 
that in untreated cells. After the blots were reprobed 
with  Ab2,  the  94 kda  band  became  much  more 
pronounced  in  all  samples  (Fig. 2A,  middle  pan‑
els), while the lower‑molecular‑mass isoforms were 
not detected. Analysis of Gr/actin ratios revealed 
that SIn‑1 and H2o2 treatments produced a slight 
decrease and an increase, respectively in intensity 
of the 94‑kda band, although these differences were 
not statistically significant (Fig. 2B).
In  principle,  changes  of  Gr  binding  activity 
such as those registered in our study upon treat‑
ment of PBMc extracts with SIn‑1, that is decrease 
Fig. 2. Effect of oxidizing agents on GR protein level in PBMCs of healthy adult donors. (A) Representative 
immunoblots of GR expression in cells of two healthy adult donors before and after the treatment with 1 mM 
SIN 1, 1 mM SNAP, or 1 mM H2O2 obtained with antibody Ab1 (upper panels) and antibody Ab2 (middle 
panels). Actin (lower panels) was used as an equal load control. (B) Cumulative quantitative data on the 
relative level of full-length GR (94-kDa) bands obtained with Ab2. The integrated optical densities of bands, 
determined with ImageQuant software, were normalized to actin. Results are expressed as means ± SEM for 
two independent determinations.t. PErIšIć Et Al. 536
Fig. 1. Western blot analysis of nitrotyrosine modified proteins 
in cellular extracts of mononuclear cells. Bovine serum albumin 
treated with 10 mM SIN 1 for 2 h at 37ºC in PBS, pH 7.4, was 
used as a positive control (lane 1). Nitrotyrosine was not detect-
ed in untreated PMBCs of healthy adult donors (lane 3) or cells 
treated with 1 mM SIN 1 for 6 h at 37ºC (lane 4). The positions 
of molecular mass reference proteins are shown in lane 2.
in both Gr number and hormone–binding affinity, 
could be a consequence of the receptor’s covalent 
modification. Since SIn‑1 is known to release no 
and o2¯, which react to produce a powerful oxidant 
and nitrating agent, ono2¯, we used an antibody 
raised against the protein nitrotyrosine to check for 
nitration of proteins, specifically the Gr, upon treat‑
ment with SIn‑1. However, in our experiment no 
nitrated proteins in SIn‑1–treated cellular extracts 
of PBMcs were detected, while BSA, used as a posi‑
tive  control,  was  succesfully  nitrated  by  the  same 
treatment (Fig. 3).
dIScuSSIon
In the present study, treatment of PBMcs of healthy 
adult blood donors with H2o2 was found to induce 
alterations  of  Gr  binding  parameters,  including 
decrease in the receptor’s affinity for the ligand and 
increase  in  the  number  of  receptor  sites  per  cell. 
these alterations were similar to those observed in 
PBMcs isolated from the blood of pediatric patients 
suffering  from  moderate  asthma,  which  in  that 
respect differed from mild asthmatics and healthy 
controls (Perišić et al., 2008). Moreover, the pat‑
tern of Gr protein bands obtained after treatment 
of PBMcs with H2o2 also resembled that observed 
in  PBMcs  of  moderate  asthmatics  (Perišić  et 
al., unpublished data). the similarity between the 
Gr  alterations  produced  by  ex  vivo  treatment  of 
PBMcs with H2o2 and those observed in PBMcs of 
moderate asthmatics suggests that pediatric moder‑
ate asthma might be associated with structural and 
functional modifications of the Gr that are likely to 
result from H2o2‑mediated oxidative stress.
there  is  considerable  evidence  that  some 
post‑translational modifications of the receptor can 
influence its ability to bind hormone. oxidizing con‑
ditions such as those created by H2o2 treatment were 
previously shown to promote formation of intramo‑
lecular  disulfide  bonds,  which  alter  the  structure 
(Silva and cidlowski, 1989; Meshinchi et 
al., 1990) and/or reversibly inactivate steroid‑bind‑
ing activity (Meshinchi et al., 1990; Makino 
et al., 1996) of the receptor. In this study, we found 
that treatment with H2o2 can induce a considerable 
decrease in ligand‑binding affinity (i.e., increase of 
kd), accompanied by increase in both the number 
of hormone‑binding sites and levels of the Gr pro‑
tein in PBMcs from healthy donors. on the other 
hand, SnAP, as a no donor, did not provoke any 
changes  of  Gr  function,  whereas  SIn‑1,  being  a 
ono2¯ donor, dramatically reduced both Gr bind‑
ing  parameters.  the  differences  in  effects  of  the 
oxidizing agents applied can probably be ascribed 
to  different  chemical  modifications  of  the  recep‑
tor. In contrast to studies presenting evidence for 
distinct effects of no‑donating compounds on Gr 
affinity for the hormone in vivo (Galigniana et 
al., 1999; Paul‑clark et al., 2003), influence of 
the ono2¯ donor SIn‑1 on Gr binding properties 
has not yet been investigated. It has been experi‑
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both  in  oxygenated  solution  and  in  physiological 
conditions, SIn‑1 releases no and o2¯. the product 
of their simultaneous reaction is ono2¯, a potent 
oxidizing agent that has been suggested to play a 
role  in  several  pathological  conditions,  including 
asthma (Saleh et al., 1998). Although the forma‑
tion of nitrotyrosine is considered to be an indica‑
tor  of  ono2¯  presence  and  activity,  in  our  study 
anti‑nitrotyrosine antibody failed to recognize cor‑
responding epitopes in cellular extracts of PBMcs 
treated  with  SIn‑1.  this  result  suggests  that  the 
herein  observed  decrease  in  Gr  number  and  its 
hormone‑binding affinity was not a consequence of 
Gr nitration, or that these changes were indirectly 
induced by SIn‑1 treatment. Additionally, it is also 
possible that the level of Gr nitration was too low to 
be detected by immunoblotting, or that intracellular 
conditions hampered ono2¯ formation, prompting 
SIn‑1 to behave more like a no donor (Singh et 
al., 1999). thus, the precise mechanisms governing 
the observed functional modifications and changes 
of Gr expression in mononuclear cells, including 
delineation between direct and indirect roles of oxi‑
dants, remain to be elucidated.
In regard to the role of inflammatory mediators 
in  asthma  pathophysiology  and  in  glucocorticoid 
resistance, elevated Gr number and diminished Gr 
binding affinity have been described in asthmatic 
patients (Sher et al., 1994), as well as in PBMcs 
from healthy donors after treatment with Il‑2 and 
Il‑4 (kam et al., 1993). the underlying mechanism 
of alterations in Gr binding parameters has not yet 
been  described.  However,  an  increasing  number 
of studies indicate that cytokines initiate the pro‑
duction of reactive oxygen and nitrogen species in 
various cell types (ohba et al., 1994; Bohler et 
al., 2000). this cross‑talk  between cytokines and 
reactive species supports the assumption that a reac‑
tive species‑mediated mechanism might be associ‑
ated with the changes in Gr binding characteristics 
observed after treatment with cytokines.
In our study, the Gr level in PBMcs was also 
examined by Western blot analysis. the observed 
SIn‑1– and H2o2‑induced changes in the Gr pro‑
tein level, measured by Western blot, were parallel 
to those in the number of dexamethasone‑binding 
sites determined by radioligand binding assay. Being 
based on the use of antibodies that recognize epi‑
topes in denatured polypeptides, the Western blot 
method provided the means to detect Gr protein 
regardless of its hormone‑binding activity. In con‑
trast, only receptor molecules that are unoccupied 
by  the  hormone  can  be  detected  by  radioligand 
binding  assay.  thus,  immunoblotting  is  a  way  to 
assess the Gr protein level that results from the bal‑
ance  between  receptor  synthesis  and  degradation, 
whereas  binding  studies  disclose  only  functional 
receptor  molecules  that  are  able  to  bind  ligand. 
Any discrepancy between results of the two meth‑
ods  suggests  that  the  mechanisms  regulating  the 
receptor’s  binding  activity  are  implicated.  In  our 
study, however, treatment of mononuclear cells with 
oxidative agents produced changes in the number of 
functional Gr molecules, which can be explained by 
similar changes in the Gr protein level, suggesting 
that the agents applied did not affect regulation of 
Gr binding activity. this suggestion seemingly con‑
tradicts our finding that H2o2 provoked a significant 
decrease in the receptor’s affinity for the hormone, 
as well as the well documented fact that H2o2 can 
inactivate steroid‑binding activity of the Gr, pro‑
moting formation of intramolecular disulfide bonds 
(Silva  and  cidlowski,  1989;  Meshinchi 
et  al.,  1990).  However,  inasmuch  as  treatment  of 
PBMcs with H2o2 was herein shown to lead to a 
considerable increase in the receptor protein level, 
it can be assumed that this increase is large enough 
to overcome the peroxide‑induced diminishment of 
the receptor’s hormone‑binding activity. 
It is well known that a cell’s sensitivity to glu‑
cocorticoids is directly determined by the level and 
molecular nature of the Gr therein, and that human 
tissues  harbor  multiple  isoforms  of  this  protein, 
some of which (e.g., Grα and Grβ) are the products 
of alternative splicing of the Gr gene (oakley et 
al., 1996), while others are generated from a single 
Gr  mrnA  species  by  alternative  translation  ini‑
tiation (lu and cidlowski, 2005).  one of the 
antibodies used in this study (Ab1) was previously 
shown  to  recognize  some  of  these  isoforms  (lu 
and cidlowski, 2005) and is therefore suitable 
for  investigating  treatment‑specific  differences  in t. PErIšIć Et Al. 538
molecular properties of the Gr in PBMcs. It was 
found that H2o2 treatment specifically modulated 
the pattern of immunospecific Gr bands, consider‑
ably increasing intensity of the 60‑kda species over 
that of the corresponding band in untreated cells of 
healthy volunteers. Interestingly, a very similar pat‑
tern of immunospecific bands was obtained from 
PBMcs of pediatric patients suffering from moder‑
ate asthma, while mild asthmatics presented a pat‑
tern resembling that of healthy subjects (Perišić 
et al., unpublished data). Since at this moment the 
precise cellular roles and intracellular localization of 
different Gr isoforms are far from being elucidated, 
it is premature to speculate on the possible biological 
significance of this finding. Besides, it should be first 
established whether the 60‑kda species represents 
an isoform or a proteolytic product of the Gr.
It is demonstrated in this paper that the altera‑
tions  of  Gr  binding  properties  and  the  protein 
expression  pattern  induced  by  H2o2  treatment  of 
PBMcs  from  healthy  donors  are  very  similar  to 
those registered in PBMcs of moderate asthmatic 
patients  in  comparison  with  mild  asthmatics  and 
healthy subjects. In contrast, treatment with other 
oxidants produced different effects or had no influ‑
ence on Gr binding activity and the protein expres‑
sion pattern. It follows that this study provides pre‑
liminary data suggesting that functional alterations 
of the Gr associated with moderate asthma may be 
mediated by redox mechanisms relying on the oxi‑
dative and regulatory actions of H2o2. 
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МОГУЋА УЛОГА ВОДОНИК ПЕРОКСИДА У ФУНКЦИОНАЛНИМ ПРОМЕНАМА 
ГЛУКОКОРТИКОИДНОГ РЕЦЕПТОРА У АСТМИ
ТаТјана Перишић1, М. Срећковић2 и Гордана МаТић1
1 Одељење за биохемију, Институт за биолошка истраживања „Синиша Станковић”, 11000 Београд, Србија
2 Дечја болница за плућне болести и туберкулозу, Клинички центар „Др Драгиша Мишовић”, 11000 Београд, Србија
Познато је да су патогенеза и напредовање 
хроничﾭне  астме  повезани  са  функﾭционалﾭним 
променама  глﾭукﾭокﾭортикﾭоидног  рецептора  (Gr) 
и  дуготрајном  инфлﾭамацијом  дисајних  путева, 
чﾭији су медијатори реакﾭтивне врсте кﾭисеоникﾭа 
и азота. У овом раду тестиралﾭи смо хипотезу да 
функﾭционалﾭне промене Gr у астми настају кﾭао 
послﾭедица  делﾭовања  окﾭсиданата.  У  том  циљу 
спровелﾭи смо серију ex vivo третмана мононукﾭлﾭе‑
арних  ћелﾭија  периферне  кﾭрви  здравих  донора 
окﾭсидујућим  агенсима  (3‑морфолﾭиносиднони‑
мином, SIn‑1; S‑нитрозо‑n‑ацетилﾭ‑пеницилﾭами‑
ном, SnAP; и водоникﾭ перокﾭсидом, H2о2) и упо‑
редилﾭи насталﾭе модификﾭације Gr са онима кﾭоје 
су раније запажене кﾭод астматичﾭних пацијената. 
резулﾭтати су покﾭазалﾭи да је третман периферних 
лﾭимфоцита водоникﾭ перокﾭсидом изазвао повећа‑
ње кﾭонцентрације Gr протеина, кﾭоје је билﾭо пра‑
ћено повећањем броја места везивања хормона и 
смањењем афинитета рецептора према хормону. 
Промене индукﾭоване водоникﾭ перокﾭсидом, укﾭљу‑
чﾭујући и кﾭаракﾭтеристичﾭну екﾭспресију изоформи 
Gr  протеина,  билﾭе  су  врлﾭо  слﾭичﾭне  променама 
кﾭоје су раније запажене у периферним лﾭимфо‑
цитима пацијената оболﾭелﾭих од средње тешкﾭог 
облﾭикﾭа астме, алﾭи не и кﾭод блﾭагих астматичﾭара 
и здравих донора. Третман другим примењеним 
окﾭсидантима произвео је другачﾭије ефекﾭте, илﾭи 
није имао утицаја на Gr. Према томе, ова студија 
је далﾭа прелﾭиминарне податкﾭе кﾭоји укﾭазују да су 
функﾭционалﾭне промене Gr повезане са средње 
тешкﾭом  астмом  вероватно  посредоване  редокﾭс 
механизмима кﾭоји се заснивају на окﾭсидативној 
и регулﾭаторној улﾭози водоникﾭ перокﾭсида.